Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis

The Lancet

Volumn 375, Issue 9719, 2010, Pages 1007-1013

  McCormick, Jonathan ^a   Mehta, Gita ^b   Olesen, Hanne V ^c   Viviani, Laura ^d   Macek Jr , Milan ^e   Mehta, Anil ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF MILAN   (Italy)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHILDHOOD MORTALITY; COMPARATIVE STUDY; CYSTIC FIBROSIS; DATA BASE; DEMOGRAPHY; EUROPE; EUROPEAN UNION; GENOTYPE; HUMAN; PRIORITY JOURNAL; REGISTER; SEX RATIO;

EID: 77949728437     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62161-9     Document Type: Article

References (23)

1. Fitzsimmons S.C. The changing epidemiology of cystic fibrosis. J Paediatr 122 (1993) 1-9
2. Corey M., and Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1971-1989. Am J Epidemiol 143 (1996) 1007-1017
3. McKone E.F., Goss C.H., and Aitken M.L. CFTR genotype as a predictor of mortality in cystic fibrosis. Chest 130 (2006) 1441-1447
4. Schechter M.S., Shelton B.J., Margolis P.A., and Fitzsimmons S.C. The association with socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 163 (2001) 1331-1337
5. O'Connor G.T., Quinton H.B., Kneeland T., et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 111 (2003) e333-e339
6. In: Stern M., Sens B., Wiedemann B., Busse O., Damm G., and Wenzlaff P. (Eds). Qualitätssicherung mukoviszidose (2009), Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin
7. Bellis G., Cazes M.H., Parant A., et al. Cystic fibrosis mortality trends in France. J Cyst Fibros 6 (2007) 179-186
8. Sims E.J., McCormick J., Mehta A., and on behalf of the UK CF Database Steering Committee. Newborn screening for cystic fibrosis is associated with reduced treatment intensity. J Pediatr 147 (2005) 306-311
9. Sims E.J., Clark A., McCormick J., Mehta G., Connett G., Mehta A., and on behalf of the UK CF Database Steering Committee. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 119 (2007) 19-28
10. Sims E.J., Mugford M., Clark A., et al., on behalf of the UK Cystic Fibrosis Database Steering Committee. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Lancet 369 (2007) 1187-1195
11. McCormick J., Sims E.J., Green M.W., Mehta G., Culross F., and Mehta A. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros 4 (2005) 115-122
12. Bobadilla J.L., Macek Jr. M., Fine J.P., and Farrell P.M. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 19 (2002) 576-606
13. Olesen H.V., Zolin A., and Viviani L. European Registry for Cystic Fibrosis report (2006 data). http://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFRreportA20 06.pdf (accessed Dec 9, 2009).
14. Statistics Division, and UN Department of Economic and Social Affairs. Gross domestic product and gross domestic product per capita. Statistical yearbook, 52nd issue (2008), United Nations, New York, NY 171-188
15. Stern M., Lindblad A., Viviani L., Ravilly S., and Olesen H.V. ECFS Registry definition consensus meeting (2007). http://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ecfs_ registry_definition_consensus_meeting.pdf (accessed Aug 12, 2009).
16. Mehta G., Sims E.J., Culross F., McCormick J., and Mehta A. Potential benefits of the UK Cystic Fibrosis Database. J R Soc Med 97 (2004) 60-71
17. Dodge J.A., Lewis P.A., Stanton M., and Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 29 (2007) 522-526
18. Koch C., McKenzie S.G., Kaplowitz H., et al. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF). Pediatr Pulmonol 24 (1997) 147-154
19. Mastella G., Rainisio M., Harms H.K., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 16 (2000) 464-471
20. Olesen H.V., and Viviani L. European Cystic Fibrosis Registry report (2004-05 data). http://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/Registry_Repo rt.pdf (accessed Aug 12, 2009).
21. Cystic Fibrosis Foundation. Patient registry: annual data report, 2007 (2008), Cystic Fibrosis Foundation, Bethesda, MD
22. Farrell P.M. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 7 (2008) 450-453
23. Fogarty A., Hubbard R., and Britton J. International comparison of median age at death from cystic fibrosis. Chest 117 (2000) 1656-1660